Ventyx Biosciences, Inc. (VTYX) Tops Q2 EPS by 7c

Ventyx Biosciences, Inc. (NASDAQ: VTYX) reported Q2 EPS of ($0.39), $0.07 better than the analyst estimate of ($0.46).

For earnings history and earnings-related data on Ventyx Biosciences, Inc. (VTYX) click here.

You May Also Be Interested In

• onsemi downgraded by TD Cowen after Synaptics deal clouds growth story
• Johnson & Johnson (JNJ) PT Raised to $270 at Guggenheim
• Apogee Enterprises (APOG) Tops Q1 EPS by 16c, Beats on Revenue; Offers FY27 Guidance